4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-24-048230
EVP & Chief Financial Officer acquired 75,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| O'Byrne Jason EVP & Chief Financial Officer | 2024-11-15 | Grant or award 10b5-1 | +75,000 | 75,000 | D | ||
| Derivatives | |||||||
| O'Byrne Jason EVP & Chief Financial Officer | 2024-11-15 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +150,000 | 150,000 | D | ||
Loading xslF345X05/wk-form4_1731954966.xml…